In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages

Clinical Microbiology and Infection

Volumn 8, Issue 12, 2002, Pages 810-813

  Ekinci, B ^a   Coban, A Y ^a   Birinci, A ^a   Durupinar, B ^a   Erturk, M ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Cefotoxime; Ceftriaxone; Macrophage; Salmonella typhi

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; GENTAMICIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL DIFFERENTIATION; CELL ISOLATION; CULTURE MEDIUM; DILUTION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SALMONELLA TYPHI;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA TYPHI;

EID: 0036940597     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00457.x     Document Type: Article

References (18)

1. Chang HR, Vladoianu IR, Pechere JC. Effects of ampicillin, ceftriaxone, pefloxacin, and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother 1990; 26: 689-94.
2. Sizemore DR, Elsinghorst EA, Eck LC et al. Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages. Infect Immun 1997; 65: 309-12.
3. s macrophages correlates with nitric oxide production. J Infect Dis 1997; 176: 1552-8.
4. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986; 83: 5189-93.
5. 3H) ampicillin-loaded nanoparticles. J Antimicrob Chemother 1996; 37: 105-15.
6. Coligan JE, Kruisbeek AM, Morgulies DH, Schevach EM, Strober W. In: Coligan et al, eds. Current protocols in immunology. Indianapolis, IN, USA: Wiley, 1994: Section 7.1-7.6.
7. Buchmeier NA, Heffron F. Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages. Infect Immun 1989; 57: 1-7.
8. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr WC. Color atlas and textbook of diagnostic microbiology, 5th edn. Philadelphia: Lippincott, 1997: 171-251.
9. Isenberg HD. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992: Section 5.2-5.3.
10. Buchmeier NA, Libby SJ. Dynamics of growth and death within a Salmonella typhimurium population during infection of macrophages. Can J Microbiol 1997; 43: 29-34.
11. Oh YK, Aranda CA, Berthiaume E, Jinks T, Miller SI, Swanson JA. Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect Immun 1996; 64: 3877-83.
12. Shiloh MU, Ruan J, Nathan C. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect Immun 1997; 65: 3193-8.
13. Bilgehan H. Klinik mikrobiyolojik taný, 2nd edn. Ýzmir: Barýp Yayýnlarý, 1995: 117-46.
14. Buchmeier NA, Heffron F. Induction of Salmonella stress proteins upon infection of macrophages. Science 1990; 248: 730-2.
15. Bhat KG, Andrade AT, Kardesai SG, Hemashethar BM, Patil CS. Antimicrobial susceptibility of Salmonella typhi to quinolones and cephalosporins. Ind J Med Res 1998; 107: 247-51.
16. Topçu AW, Söyletir G, Doanay M. Ýnfeksiyon hastalýklarý. Istanbul: Nobel Týp Kitabevleri, 1996: 491-505.
17. Ünal S, Hayran M, Tuncer S et al. Treatment of enteric fever with pefloxacin for 7 days versus 5 days. Randomized clinical trial. Antimicrob Agents Chemother 1996; 40: 2898-900.
18. Van Den Broek PJ, Buys LFM, Van Den Barselaar MT, Leijh PCJ, Van Furth R. Influence of human monocytes on the antibacterial activity of kanamycin and gentamicin for Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29: 1032-9.